SG/CALL/SARTORIUS STEDIM BIO/200/0.025/21.03.25 Stock

Warrant

381XS

DE000SY122R7

Market Closed - Euronext Paris 02:02:39 2024-07-02 EDT
0.32 EUR -5.88% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/200/0.025/21.03.25
Current month-12.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-02 0.32 -5.88%
24-07-01 0.34 -12.82%
24-06-28 0.39 -4.88%
24-06-27 0.41 -8.89%
24-06-26 0.45 0.00%

Real-time Euronext Paris

Last update July 02, 2024 at 02:02 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
381XS
ISINDE000SY122R7
Date issued 2024-06-20
Strike 200
Maturity 2025-03-21 (263 Days)
Parity 40 : 1
Emission price 0.55
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.475
Lowest since issue 0.32
Delta0.36x
Omega 3.967
Premium45.33x
Gearing11.11x
Moneyness 0.7335
Difference Strike 53.3
Difference Strike %+26.65%
Spread 0.02
Spread %5.88%
Theoretical value 0.3300
Implied Volatility 55.67 %
Total Loss Probability 79.91 %
Intrinsic value 0.000000
Present value 0.3300
Break even 213.20 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
146.7 EUR
Average target price
247.2 EUR
Spread / Average Target
+68.48%
Consensus
  1. Stock Market
  2. Warrants
  3. 381XS Warrant